Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis.
Lok AS, McMahon BJ, Brown RS Jr, Wong JB, Ahmed AT, Farah W, Almasri J, Alahdab F, Benkhadra K, Mouchli MA, Singh S, Mohamed EA, Abu Dabrh AM, Prokop LJ, Wang Z, Murad MH, Mohammed K.
Hepatology. 2016 Jan;63(1):284-306. doi: 10.1002/hep.28280. Epub 2015 Nov 13.
PMID:26566246
AASLD guidelines for treatment of chronic hepatitis B.
Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH; American Association for the Study of Liver Diseases.
Hepatology. 2016 Jan;63(1):261-83. doi: 10.1002/hep.28156. Epub 2015 Nov 13.
PMID:26566064
Chronic hepatitis B and non-alcoholic fatty liver disease: Conspirators or competitors?
Zhang J, Lin S, Jiang D, Li M, Chen Y, Li J, Fan J.
Liver Int. 2020 Mar;40(3):496-508. doi: 10.1111/liv.14369. Epub 2020 Jan 13.
PMID:31903714
[Chronic hepatitis B virus infection: current and future treatment strategies].
The 2024 updated WHO guidelines for the prevention and management of chronic hepatitis B: Main changes and potential implications for the next major liver society clinical practice guidelines.
Wong GL, Lemoine M.
J Hepatol. 2025 May;82(5):918-925. doi: 10.1016/j.jhep.2024.12.004. Epub 2024 Dec 6.
PMID:39647534
Overview of chronic hepatitis B management.
Jun A, Bau S, Kim JS, Phillips SJ.
Nurse Pract. 2025 Jan 1;50(1):7-13. doi: 10.1097/01.NPR.0000000000000246. Epub 2024 Dec 19.